Dianthus Therapeutics (DNTH) Shares Outstanding (Diluted Average) (2020 - 2025)

Dianthus Therapeutics has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $36.5 million in Q3 2025.

• For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) rose 6.54% year-over-year to $36.5 million; the trailing twelve-month figure through Sep 2025 stood at $36.5 million (up 6.54% YoY), and the FY2024 full-year result was $33.3 million, up 546.44% from the prior year.
• Shares Outstanding (Diluted Average) for Q3 2025 stood at $36.5 million, up from $35.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $58.8 million in Q2 2022, with the low at $874138.0 in Q3 2022.
• Average Shares Outstanding (Diluted Average) over 5 years is $30.3 million, with a median of $34.2 million recorded in 2024.
• Year-over-year, Shares Outstanding (Diluted Average) tumbled 98.51% in 2023 and jumped 3534.12% in 2024.
• Tracing DNTH's Shares Outstanding (Diluted Average) over 5 years: stood at $54.9 million in 2021, then sank by 98.41% to $874234.0 in 2022, then jumped by 489.48% to $5.2 million in 2023, then soared by 546.44% to $33.3 million in 2024, then grew by 9.49% to $36.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $36.5 million (Q3 2025), $35.8 million (Q2 2025), and $35.8 million (Q1 2025), per Business Quant data.

Peer Comparison